Microbiota-derived butyrate inhibits colonic epithelial pyroptosis and mitigates DSS-induced colitis via interacting with aryl hydrocarbon receptor

Gut bacteria produce butyrate, a metabolite that now appears to protect the intestinal lining by preventing a type of inflammatory cell death—a mechanistic link that clarifies why microbiota dysfunction precedes colitis. This extends the growing but still preliminary evidence that bacterial metabolites directly govern barrier integrity through specific receptors, rather than acting as passive byproducts. Gastroenterologists and inflammatory bowel disease researchers should monitor this pathway as a potential therapeutic target, though clinical translation remains distant.